| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780021 | Gynecologic Oncology | 2018 | 6 Pages |
Abstract
Following PDS, CSR andâ¯â¤â¯1â¯cm-SL patients have the best prognosis. In contrast, despite being considered “optimally debulked”, â¤1â¯cm-ML patients have survival similar to those SO-debulked.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Beryl L. Manning-Geist, Katherine Hicks-Courant, Allison A. Gockley, Rachel M. Clark, Marcela G. del Carmen, Whitfield B. Growdon, Neil S. Horowitz, Ross S. Berkowitz, Michael G. Muto, Michael J. Jr.,